BUZZ-Valeant Pharmaceuticals: Selects trio to fill in for CEO
** Canadian drugmaker's shares down 11.05 pct at C$140.25, continues to fall for second day
** Company's U.S.-listed shares down 1.2 pct at $101
** Company on Monday said group of executives will immediately take over for its CEO until he returns from medical leave, news that sent its shares tumbling 10 percent
** Valeant CEO Michael Pearson, 56, is being treated for severe pneumonia
** The decision to put leadership in the hands of three executives was unusual, experts say, and suggests a lack of confidence in any one company executive to temporarily fill CEO's shoes
** Up to Thursday's close, company's Canada-listed stock had fallen about 5 pct this year, while its U.S.-listed stock had fallen about 20 pct
© Thomson Reuters 2017 All rights reserved.